Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Patent Litigation

full services list
Patent Litigation Image

Litigation

Post-Grant

Prosecution & Counseling

Fish Patent Litigation
High Profile, High Stakes Cases

The world’s leading companies have one thing in common: innovative products and services. That’s why they turn to Fish — the global leader in intellectual property litigation. With 12 offices across the US and in Munich, Germany, Fish protects clients’ most valuable IP business assets around the globe. We’ve earned our elite position by consistently winning the most important, technically sophisticated, bet-the-company patent cases for such clients as Microsoft, 3M, Bose, Samsung, LG, Allergan, Bank of America, and Smith & Nephew.

But one of our greatest strengths is providing long-term plans and solutions for clients, not just litigation advice. Making strategic decisions up front saves clients’ money and helps ensure a successful outcome.

Winning track record at all levels of the judicial system
Our record speaks for itself. Fish handled a total of 321 patent cases in 2015 – over triple as many cases as its nearest competitor but with the same number of people. Most important, we win the largest cases, worth billions of dollars and with whole businesses often on the line. That is why more Fortune 100 companies in the world trust Fish—over any other firm—to handle their mission-critical IP litigation.

For the past thirteen years, Corporate Counsel has named us the #1 patent litigation firm. U.S. News – Best Lawyers ®  recently named  Fish as the Patent Litigation “Law Firm of the Year”, and BTI Consulting has recognized us as an “IP Litigation Powerhouse”, to name a few honors that set us apart from the rest.

We can handle everything and are, quite simply, the absolute best at what we do.

Deep Knowledge, Seasoned Trial Lawyers, Big Wins
Fish has more than 400 attorneys and technology specialists practicing IP strategy and counseling, IP litigation, and commercial litigation. More than 300 attorneys have degrees in science or technology. Add to that the 80 PhDs on our staff, and you get a law firm with unmatched expertise in virtually every technology area. Our deep bench includes more than 70 former law clerks and over 25 former Federal Circuit clerks with in-depth knowledge of these courts, giving us an insider’s edge.

Our litigation teams include top-notch patent prosecutors who have a deep understanding of clients’ technologies, potential prior art, patent laws and rules, and the fine distinctions between claims. Together, we develop creative and winning litigation strategies that other firms would never think of.

In recent years, we have tried more than 20 percent of all the patent cases that were tried to verdict in the United States. Unlike some firms that build a practice around a single rock-star trial lawyer who tries every patent case, our attorneys have expertise in the most complex patent cases at every stage of the litigation: from Markman hearings and motions for summary judgment to trial and appeal.

There is no other firm that can match the quality, breadth, depth, and dominance of our IP litigation practice. This is why Fish wins so many significant cases day in and day out, and is often at the forefront of developing new case law.


View the Fish Litigation Blog
Back to Litigation

Patent Litigation Services




Featured Experience

Highlights

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Patent Litigation

Patent Litigation Team

What's Trending in Patent Litigation

Filter by
Fish Litigation Blog
September 30, 2016
Court Orders Entry of Final Judgment of Invalidity in Ongoing Janssen v. Celltrion BPCIA Dispute
Court Orders Entry of Final Judgment of Invalidity in Ongoing Janssen v. Celltrion BPCIA Dispute
Authors: Ethan Rubin, Jenny Shmuel, Ph.D.
IP Litigation
Life Sciences
News
September 28, 2016
Fish & Richardson Principals Juanita Brooks, Michael Headley Rank Among Daily Journal’s “Top IP Attorneys for 2016” List
Press Releases
News
September 28, 2016
Fish's John Dragseth Quoted in Law360 Article "PTAB Appeals Face Tough Road After Latest Fed. Circ. Ruling"
Media Coverage
Fish Litigation Blog
September 27, 2016
Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar
Amgen’s Humira Biosimilar Becomes the Fourth FDA Approved Biosimilar
Authors: Holly Chamberlain, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
September 21, 2016
FDA to Hold Public Meeting on Biosimilar User Fees
FDA to Hold Public Meeting on Biosimilar User Fees
Authors: Rachel Bandli, Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
News
September 21, 2016
Fish's Ryan McCarthy Quoted in Law360 Article "How Recent Case Law Can Be Used To Fight Alice Challenges"
Media Coverage
News
September 21, 2016
Fish & Richardson Named Among Most Feared Firms in Litigation in BTI Litigation Outlook 2017
Press Releases
Fish Patent Blog
September 21, 2016
PTAB Bar Association Officially Launched
PTAB Bar Association Officially Launched
Authors: Dorothy P. Whelan, W. Karl Renner, Thomas Rozylowicz
Fish Litigation Blog
September 20, 2016
Amgen Argues “Entire Balance of BPCIA” in Jeopardy unless Federal Circuit Overturns Discovery Ruling
Amgen Argues “Entire Balance of BPCIA” in Jeopardy unless Federal Circuit Overturns Discovery Ruling
Authors: Holly Chamberlain, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
September 19, 2016
The Dance Continues: Apotex Petitions the Supreme Court for Review
The Dance Continues: Apotex Petitions the Supreme Court for Review
Authors: Will Orlady, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
Life Sciences
Fish Litigation Blog
September 16, 2016
My Intellectual Property Licensor is Bankrupt – Now What?
My Intellectual Property Licensor is Bankrupt – Now What?
Author: John R. Lane
IP Litigation
News
September 15, 2016
Fish & Richardson Receives ILTA’s 2016 “Innovative Project of the Year” Award
Press Releases
load more topics